We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MDXXF market cap is 11.28M. The company's latest EPS is CAD -0.0090 and P/E is -13.33.
| Year End 31 August 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 78k | 699k | 1.04M |
| Operating Income | -2.3M | -603k | 27k | -824k |
| Net Income | -2.51M | -985k | -780k | -824k |
| Year End 31 August 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.79M | 2.33M | 2.41M | 2.9M |
| Total Liabilities | 138k | 424k | 1.03M | 917k |
| Total Equity | 2.66M | 1.91M | 1.38M | 1.98M |
| Year End 31 August 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -175k | -625k | -339k | -321k |
| Investing | 630k | -995k | -507k | -227k |
| Financing | 2.02M | N/A | 189k | 772k |
| Market Cap | 11.28M |
| Price to Earnings Ratio | -13.33 |
| Price to Sales Ratio | 10.62 |
| Price to Cash Ratio | 26.09 |
| Price to Book Ratio | 5.56 |
| Dividend Yield | - |
| Shares Outstanding | 91.72M |
| Average Volume (1 week) | 13.48k |
| Average Volume (1 Month) | 15.15k |
| 52 Week Change | -12.14% |
| 52 Week High | 0.2563 |
| 52 Week Low | 0.04005 |
| Spread (Intraday) | 0.11 (71.79%) |
| Company Name | PharmAla Biotech Holdings Inc (QB) |
| Address |
1055 west georgia street toronto, ontario V6E 4N7 |
| Website | https://www.pharmala.ca |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
